🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07039500
Recruiting Observational

Impact of Severe Obstructive Sleep Apnea-Hypopnea Syndrome on Auditory-Cognitive Processing

NCT07039500 · tracked via the Priya Life Science China tracker
Sponsor
Peking University First Hospital
Phase
Observational
Started
2024-12-11
Last updated
2025-08-07

Condition(s) studied

Obstructive Sleep ApneaAuditory Processing Disorder

Study summary

The goal of this observational study is to learn how severe obstructive sleep apnea-hypopnea syndrome (OSAHS) affects the brain's ability to process sounds and attention in adults aged 20-60 years. The main questions it aims to answer are:

1. Does severe OSAHS change how the brain automatically detects sound changes during wakefulness?
2. Does severe OSAHS reduce people's ability to pay attention to important sounds when awake?
3. Can brainwave tests (Electroencephalogram, EEG) detect early signs of hearing-related cognitive problems in OSAHS patients before symptoms appear?

Researchers will compare two groups:

* 50 adults with severe OSAHS (diagnosed by sleep tests)
* 50 healthy adults matched by age and gender

Participants will:

* Complete hearing tests (MoCA)
* Undergo a 1-night sleep test (PSG)
* Wear an EEG cap for 1.5-2 hours while listening to sounds in a quiet room:

* Passive task: Relax (no response needed)
* Active task: Press a button when hearing rare sounds
* Receive ¥75/hour compensation for their time

Eligibility

Sex
ALL
Min age
20 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: All Participants: * Aged 20-60 years * Normal hearing (PTA ≤25 dB HL at 0.5,1,2,4 kHz; Type A tympanogram) * MoCA score ≥26 * Willing to complete EEG testing OSAHS Group Additional: \- PSG-confirmed severe OSAHS (AHI \>30 events/hour) Control Group Additional: * Self-reported absence of snoring/sleep disorders * No prior OSAHS diagnosis Exclusion Criteria: All Participants: * History of: * Schizophrenia, epilepsy, Parkinson's, TBI, or language disorders * Middle/inner ear diseases (otitis media, acoustic neuroma, etc.) * Cognitive impairment or depression/anxiety disorders * Chronic steroid use * Systemic inflammatory diseases or malignancies * Pregnancy or suspected pregnancy (self-reported)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Peking University First Hospital Beijing Beijing Municipality Recruiting

More Peking University First Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07039500 on ClinicalTrials.gov ↗ ← All trials in China